Sustained high level of serum VEGF at convalescent stage contributes to the renal recovery after HTNV infection in patients with hemorrhagic fever with renal syndrome

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Ma, Ying ^a   Liu, Bei ^a   Yuan, Bin ^a   Wang, Jiuping ^b   Yu, Haitao ^b   Zhang, Yun ^a   Xu, Zhuwei ^a   Zhang, Yusi ^a   Yi, Jing ^a   Zhang, Chunmei ^a   Zhou, Xingchun ^a   Yang, Angang ^a   Zhuang, Ran ^a   Jin, Boquan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CONVALESCENCE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HANTAVIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OLIGURIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; VIRAL CLEARANCE; BLOOD; CAPILLARY PERMEABILITY; CASE CONTROL STUDY; FEVER; HANTAVIRUS INFECTION; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SERUM; VIROLOGY;

ADULT; CAPILLARY PERMEABILITY; CASE-CONTROL STUDIES; CONVALESCENCE; ENDOTHELIAL CELLS; FEMALE; FEVER; HANTAAN VIRUS; HANTAVIRUS INFECTIONS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; KIDNEY; MALE; MIDDLE AGED; SERUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84868709377     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/812386     Document Type: Article

References (51)

1. Ma C., Yu P., Nawaz M., Hantaviruses in rodents and humans, Xi'an, PR China. Journal of General Virology 2012 93 10 2227 2236
2. Zhang Y. Z., Zou Y., Fu Z. F., Plyusnin A., Hantavirus infections in humans and animals, China. Emerging Infectious Diseases 2010 16 8 1195 1203 2-s2.0-77956023499 10.3201/eid1608.090470
3. Schmaljohn C., Hjelle B., Hantaviruses: a global disease problem. Emerging Infectious Diseases 1997 3 2 95 104 2-s2.0-0031113395 (Pubitemid 127431667)
4. Zaki S. R., Greer P. W., Coffield L. M., Goldsmith C. S., Nolte K. B., Foucar K., Feddersen R. M., Zumwalt R. E., Miller G. L., Khan A. S., Rollin P. E., Ksiazek T. G., Nichol S. T., Mahy B. W. J., Peters C. J., Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. American Journal of Pathology 1995 146 3 552 579 2-s2.0-0028954686
5. Mustonen J., Helin H., Pietila K., Brummer-Korvenkontio M., Hedman K., Vaheri A., Pasternack A., Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clinical Nephrology 1994 41 3 121 126 2-s2.0-0028330849 (Pubitemid 24085373)
6. Kim S., Sung S. H., An H. R., Jun Y. H., Yu M., Ryu D. R., Kim S. J., Kang D. H., Choi K. B., A case report of crescentic glomerulonephritis associated with hantaan virus infection. Nephrology Dialysis Transplantation 2010 25 8 2790 2792 2-s2.0-77954813894 10.1093/ndt/gfq253
7. Temonen M., Mustonen J., Helin H., Pasternack A., Vaheri A., Holthöfer H., Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clinical Immunology and Immunopathology 1996 78 1 47 55 2-s2.0-0029875112 10.1006/clin.1996.0007 (Pubitemid 26079195)
8. Pepini T., Gorbunova E. E., Gavrilovskaya I. N., Mackow J. E., Mackow E. R., Andes virus regulation of cellular microRNAs contributes to hantavirus-induced endothelial cell permeability. Journal of Virology 2010 84 22 11929 11936 2-s2.0-78049511215 10.1128/JVI.01658-10
9. Khaiboullina S. F., Netski D. M., Krumpe P., Jeor S. C. S., Effects of tumor necrosis factor alpha on Sin Nombre virus infection in vitro. Journal of Virology 2000 74 24 11966 11971 2-s2.0-0034469162 10.1128/JVI.74.24.11966-11971. 2000 (Pubitemid 32222348)
10. Sundstrom J. B., McMullan L. K., Spiropoulou C. F., Hooper W. C., Ansari A. A., Peters C. J., Rollin P. E., Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. Journal of Virology 2001 75 13 6070 6085 2-s2.0-0034974905 10.1128/JVI.75.13.6070-6085.2001 (Pubitemid 32553138)
11. Mackow E. R., Gavrilovskaya I. N., Hantavirus regulation of endothelial cell functions. Thrombosis and Haemostasis 2009 102 6 1030 1041 2-s2.0-72949092475 10.1160/TH09-09-0640
12. Pensiero M. N., Sharefkin J. B., Dieffenbach C. W., Hay J., Hantaan virus infection of human endothelial cells. Journal of Virology 1992 66 10 5929 5936 2-s2.0-0026731010
13. Aird W. C., Endothelium as an organ system. Critical Care Medicine 2004 32 5, supplement S271 S279 2-s2.0-2942744464
14. Dvorak H. F., Discovery of vascular permeability factor (VPF). Experimental Cell Research 2006 312 5 522 526 2-s2.0-33344463349 10.1016/j.yexcr.2005.11.026 (Pubitemid 43290329)
15. Valbuena G., Walker D. H., The endothelium as a target for infections. Annual Review of Pathology 2006 1 171 198 2-s2.0-33645734097 10.1146/annurev.pathol.1.110304.100031
16. Hayasaka D., Maeda K., Ennis F. A., Terajima M., Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Research 2007 123 2 120 127 2-s2.0-33846027112 10.1016/j.virusres.2006.08.006 (Pubitemid 46054332)
17. + T cells trigger capillary leakage in viral hemorrhagic fevers? Immunology Letters 2007 113 2 117 120 2-s2.0-35248869184 10.1016/j.imlet.2007. 08.003 (Pubitemid 47562127)
18. Dvorak H. F., Sioussat T. M., Brown L. F., Berse B., Nagy J. A., Sotrel A., Manseau E. J., Van De Water L., Senger D. R., Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. Journal of Experimental Medicine 1991 174 5 1275 1278 2-s2.0-0025953395
19. Ferrara N., Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 2004 25 4 581 611 2-s2.0-4143136640 10.1210/er.2003-0027 (Pubitemid 39099316)
20. Schrijvers B. F., Flyvbjerg A., De Vriese A. S., The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney International 2004 65 6 2003 2017 2-s2.0-2442707596 10.1111/j.1523-1755.2004.00621.x (Pubitemid 38669987)
21. Srikiatkhachorn A., Ajariyakhajorn C., Endy T. P., Kalayanarooj S., Libraty D. H., Green S., Ennis F. A., Rothman A. L., Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever. Journal of Virology 2007 81 4 1592 1600 2-s2.0-33846830063 10.1128/JVI.01642-06 (Pubitemid 46214434)
22. Tseng C. S., Lo H. W., Teng H. C., Lo W. C., Ker C. G., Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunology and Medical Microbiology 2005 43 1 99 102 2-s2.0-11144346120 10.1016/j.femsim.2004. 10.004 (Pubitemid 40029433)
23. Gavrilovskaya I. N., Gorbunova E. E., Mackow N. A., Mackow E. R., Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. Journal of Virology 2008 82 12 5797 5806 2-s2.0-44949117721 10.1128/JVI.02397-07 (Pubitemid 351822254)
24. Chade A. R., Kelsen S., Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach. American Journal of Physiology 2012 302 10 F1342 F1350 2-s2.0-84861151993 10.1152/ajprenal.00674.2011
25. Masuda Y., Shimizu A., Kataoka M., Arai T., Ishikawa A., Du X., Saito S. K., Aki K., Nagasaka S., Mii A., Fujita E., Fukuda Y., Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis. Laboratory Investigation 2010 90 10 1468 1481 2-s2.0-77957277209 10.1038/labinvest.2010.130
26. Leonard E. C., Friedrich J. L., Basile D. P., VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. American Journal of Physiology 2008 295 6 F1648 F1657 2-s2.0-57349093841 10.1152/ajprenal.00099.2008
27. Faleo G., Neto J. S., Kohmoto J., Tomiyama K., Shimizu H., Takahashi T., Wang Y., Sugimoto R., Choi A. M. K., Stolz D. B., Carrieri G., McCurry K. R., Murase N., Nakao A., Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation 2008 85 12 1833 1840 2-s2.0-49149130917 10.1097/TP.0b013e31817c6f63
28. Wang M., Wang J., Zhu Y., Xu Z., Yang K., Yang A., Jin B., Cellular immune response to hantaan virus nucleocapsid protein in the acute phase of hemorrhagic fever with renal syndrome: correlation with disease severity. Journal of Infectious Diseases 2009 199 2 188 195 2-s2.0-58849125413 10.1086/595834
29. Thisyakorn U., Nimmannitya S., Ningsanond V., Soogarun S., Atypical lymphocyte in dengue hemorrhagic fever: its value in diagnosis. The Southeast Asian Journal of Tropical Medicine and Public Health 1984 15 1 32 36 2-s2.0-0021403626
30. Oscier D. G., Matutes E., Copplestone A., Pickering R. M., Chapman R., Gillingham R., Catovsky D., Hamblin T. J., Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. British Journal of Haematology 1997 98 4 934 939 2-s2.0-0030879857 (Pubitemid 27421638)
31. Wang T.-B., Chen Z.-G., Wei X.-Q., Wei B., Dong W.-G., Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer. ANZ Journal of Surgery 2011 81 10 694 699 2-s2.0-80053460345 10.1111/j.1445-2197.2010.05539. x
32. Dobrzycka B., Terlikowski S. J., Kowalczuk O., Kulikowski M., Niklinski J., Serum levels of VEGF and VEGF-C in patients with endometrial cancer. European Cytokine Network 2011 22 1 45 51 2-s2.0-79958025246 10.1684/ecn.2011.0276
33. Robert B., Zhao X., Abrahamson D. R., Coexpression of neuropilin-1, Flk1, and VEGF164 in developing and mature mouse kidney glomeruli. American Journal of Physiology 2000 279 2 F275 F282 2-s2.0-0033840069
34. Simon M., Röckl W., Hornig C., Gröne E. F., Theis H., Weich H. A., Fuchs E., Yayon A., Gröne H. J., Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: lsocalization and [125I]VEGF binding sites. Journal of the American Society of Nephrology 1998 9 6 1032 1044 2-s2.0-0345164367
35. Sawano A., Iwai S., Sakurai Y., Ito M., Shitara K., Nakahata T., Shibuya M., Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 2001 97 3 785 791 2-s2.0-0035254646 10.1182/blood.V97.3.785 (Pubitemid 32113414)
36. Quinn T. P., Peters K. G., De Vries C., Ferrara N., Williams L. T., Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proceedings of the National Academy of Sciences of the United States of America 1993 90 16 7533 7537 2-s2.0-0027249239 (Pubitemid 23249984)
37. Wang W., Zhang Y., Li Y., Pan L., Bai L., Zhuang Y., Huang C.-X., Wang J.-P., Yu H.-T., Wei X., Jiang W., Nan Y.-Y., Yang D.-Q., Su W.-J., Wang P.-Z., Bai X.-F., Dysregulation of the beta3 integrin-VEGFR2 complex in Hantaan virus-directed hyperpermeability upon treatment with VEGF. Archives of Virology 2012 157 6 1051 1061 2-s2.0-84862798115 10.1007/s00705-012-1245-7
38. Gavrilovskaya I. N., Peresleni T., Geimonen E., Mackow E. R., Pathogenic hantaviruses selectively inhibit β 3 integrin directed endothelial cell migration. Archives of Virology 2002 147 10 1913 1931 2-s2.0-0036402322 10.1007/s00705-002-0852-0 (Pubitemid 35218716)
39. Hodivala-Dilke K. M., McHugh K. P., Tsakiris D. A., Rayburn H., Crowley D., Ullman-Culleré M., Ross F. P., Coller B. S., Teitelbaum S., Hynes R. O., β 3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. Journal of Clinical Investigation 1999 103 2 229 238 2-s2.0-0032590042 (Pubitemid 29053141)
40. 5 integrins. Nature Medicine 2002 8 1 27 34 2-s2.0-0036152857 10.1038/nm0102-27 (Pubitemid 34101725)
41. Robinson S. D., Reynolds L. E., Wyder L., Hicklin D. J., Hodivala-Dilke K. M., β 3-integrin regulates vascular endothelial growth factor-A-dependent permeability. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 11 2108 2114 2-s2.0-8344265218 10.1161/01.ATV.0000143857.27408. de (Pubitemid 39482438)
42. Zachary I., Vascular endothelial growth factor: how it transmits its signal. Experimental Nephrology 1998 6 6 480 487 2-s2.0-0031770547 (Pubitemid 28518369)
43. Liu E., Morimoto M., Kitajima S., Koike T., Yu Y., Shiiki H., Nagata M., Watanabe T., Fan J., Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. Journal of the American Society of Nephrology 2007 18 7 2094 2104 2-s2.0-34447265300 10.1681/ASN.2006010075 (Pubitemid 47041075)
44. Gorbunova E., Gavrilovskaya I. N., Mackow E. R., Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cell. Journal of Virology 2010 84 14 7405 7411 2-s2.0-77953763318 10.1128/JVI.00576-10
45. Gavrilovskaya I. N., Gorbunova E. E., Mackow E. R., Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. Journal of Virology 2010 84 9 4832 4839 2-s2.0-77950813111 10.1128/JVI.02405-09
46. Berger M. M., Hesse C., Dehnert C., Siedler H., Kleinbongard P., Bardenheuer H. J., Kelm M., Bärtsch P., Haefeli W. E., Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema. American Journal of Respiratory and Critical Care Medicine 2005 172 6 763 767 2-s2.0-24944498766 10.1164/rccm.200504-654OC (Pubitemid 41324233)
47. Dehler M., Zessin E., Bärtsch P., Mairbäurl H., Hypoxia causes permeability oedema in the constant-pressure perfused rat lung. European Respiratory Journal 2006 27 3 600 606 2-s2.0-33644858320 10.1183/09031936.06. 00061505 (Pubitemid 43372536)
48. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z., Vascular endothelial growth factor (VEGF) and its receptors. FASEB Journal 1999 13 1 9 22 2-s2.0-0032907687 (Pubitemid 29038270)
49. Pham I., Uchida T., Planes C., Ware L. B., Kaner R., Matthay M. A., Clerici C., Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. American Journal of Physiology 2002 283 5 L1133 L1142 2-s2.0-0036838846 (Pubitemid 35204907)
50. Stenmark K. R., Fagan K. A., Frid M. G., Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circulation Research 2006 99 7 675 691 2-s2.0-33749345684 10.1161/01.RES.0000243584.45145.3f (Pubitemid 44498302)
51. Yi J., Xu Z., Zhuang R., Hantaan virus RNA load in patients having hemorrhagic fever with renal syndrome: correlation with disease severity. Journal of Infectious Diseases. In press 10.1093/infdis/jis475